Výsledky vyhledávání - Terui, Yasuhito
- Zobrazuji výsledky 1 - 20 z 32
- Přejít na další stránku
-
1
-
2
-
3
Effective collaboration between hematologists and cardiologists facilitated successful control of reversible dasatinib-related pulmonary arterial hypertension and treatment-free re... Autor Hua, Zhensheng, Oyakawa, Takuya, Ebihara, Aya, Terui, Yasuhito, Shiga, Taro
Vydáno 2022Text -
4
Preferential Production of Interleukin‐1β over Interleukin‐1 Receptor Antagonist Contributes to Proliferation and Suppression of Apoptosis in Leukemic Cells Autor Furukawa, Yusuke, Kikuchi, Jiro, Terui, Yasuhito, Kitagawa, Seiichi, Ohta, Masatsugu, Miura, Yasusada, Saito, Masaki
Vydáno 1995Text -
5
Intravascular Large B-cell Lymphoma of the Bilateral Ovaries and Uterus in an Asymptomatic Patient with a t(11;22)(q23;q11) Constitutional Translocation Autor Shigematsu, Yasuyuki, Matsuura, Motoki, Nishimura, Noriko, Tsuyama, Naoko, Takeuchi, Kengo, Terui, Yasuhito, Takeshima, Nobuhiro, Hatake, Kiyohiko
Vydáno 2016Text -
6
Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymp... Autor Yokoyama, Masahiro, Kusano, Yoshiharu, Inoue, Norihito, Nishimura, Noriko, Mishima, Yuko, Nukada, Tomoyuki, Hatake, Kiyohiko, Terui, Yasuhito
Vydáno 2021Text -
7
-
8
Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas Autor Tsuyama, Naoko, Ennishi, Daisuke, Yokoyama, Masahiro, Baba, Satoko, Asaka, Reimi, Mishima, Yuko, Terui, Yasuhito, Hatake, Kiyohiko, Takeuchi, Kengo
Vydáno 2017Text -
9
Final results of a phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma Autor Maruyama, Dai, Terui, Yasuhito, Yamamoto, Kazuhito, Fukuhara, Noriko, Choi, Ilseung, Kuroda, Junya, Ando, Kiyoshi, Hattori, Akira, Tobinai, Kensei
Vydáno 2020Text -
10
Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2) Autor Yokoyama, Masahiro, Kusano, Yoshiharu, Nishihara, Anna, Inoue, Norihito, Nishimura, Noriko, Mishima, Yuko, Terui, Yasuhito, Nukada, Tomoyuki, Nomura, Takanobu, Hatake, Kiyohiko
Vydáno 2019Text -
11
Phase I study of obinutuzumab (GA101) in Japanese patients with relapsed or refractory B‐cell non‐Hodgkin lymphoma Autor Ogura, Michinori, Tobinai, Kensei, Hatake, Kiyohiko, Uchida, Toshiki, Suzuki, Tatsuya, Kobayashi, Yukio, Mori, Masakazu, Terui, Yasuhito, Yokoyama, Masahiro, Hotta, Tomomitsu
Vydáno 2012Text -
12
A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myeloma Autor Iida, Shinsuke, Izumi, Tohru, Komeno, Takuya, Terui, Yasuhito, Chou, Takaaki, Ikeda, Takashi, Berg, Deborah, Fukunaga, Shinichi, Sugiura, Kenkichi, Sasaki, Makoto
Vydáno 2021Text -
13
Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma Autor Nitta, Hideaki, Terui, Yasuhito, Yokoyama, Masahiro, Mishima, Yuko, Nishimura, Noriko, Ueda, Kyoko, Kusano, Yoshiharu, Tsuyama, Naoko, Takeuchi, Kengo, Kanda, Yoshinobu, Hatake, Kiyohiko
Vydáno 2015Text -
14
Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan Autor Yokoyama, Masahiro, Kusano, Yoshiharu, Takahashi, Anna, Inoue, Norihito, Ueda, Kyoko, Nishimura, Noriko, Mishima, Yuko, Terui, Yasuhito, Nukada, Tomoyuki, Nomura, Takanobu, Hatake, Kiyohiko
Vydáno 2017Text -
15
HIV positivity may not have a negative impact on survival in Epstein-Barr virus-positive Hodgkin lymphoma: A Japanese nationwide retrospective survey Autor Yotsumoto, Mihoko, Ito, Yoshikazu, Hagiwara, Shotaro, Terui, Yasuhito, Nagai, Hirokazu, Ota, Yasunori, Ajisawa, Atsushi, Uehira, Tomoko, Tanuma, Junko, Ohyashiki, Kazuma, Okada, Seiji
Vydáno 2018Text -
16
Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan Autor Yokoyama, Masahiro, Terui, Yasuhito, Takeuchi, Kengo, Nara, Eriko, Nakano, Kenji, Ueda, Kyoko, Nishimura, Noriko, Mishima, Yuko, Sakajiri, Sakura, Tsuyama, Naoko, Ozawa, Keiya, Hatake, Kiyohiko
Vydáno 2013Text -
17
CTNI-66. ONE-YEAR FOLLOW-UP DATA OF PHASE I/II STUDY OF TIRABRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA Autor Mishima, Kazuhiko, Narita, Yoshitaka, Nagane, Motoo, Terui, Yasuhito, Arakawa, Yoshiki, Yonezawa, Hajime, Asai, Katsunori, Fukuhara, Noriko, Sugiyama, Kazuhiko, Shinojima, Naoki, Aoi, Arata, Nishikawa, Ryo
Vydáno 2020Text -
18
ML-05 One-year follow-up data of phase I/II study of tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma Autor Mishima, Kazuhiko, Narita, Yoshitaka, Nagane, Motoo, Terui, Yasuhito, Arakawa, Yoshiki, Yonezawa, Hajime, Asai, Katsunori, Fukuhara, Noriko, Sugiyama, Kazuhiko, Shinojima, Naoki, Aoi, Arata, Nishikawa, Ryo
Vydáno 2020Text -
19
Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study Autor Kinoshita, Tomohiro, Hatake, Kiyohiko, Yamamoto, Kazuhito, Higuchi, Yusuke, Murakami, Satsuki, Terui, Yasuhito, Yokoyama, Masahiro, Maruyama, Dai, Makita, Shinichi, Hida, Yukari, Saito, Tomohisa, Tobinai, Kensei
Vydáno 2020Text -
20
Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Autor Ogura, Michinori, Hatake, Kiyohiko, Tobinai, Kensei, Uchida, Toshiki, Suzuki, Tatsuya, Terui, Yasuhito, Yokoyama, Masahiro, Maruyama, Dai, Mori, Masakazu, Jewell, Roxanne C., Katsura, Koichi, Hotta, Tomomitsu
Vydáno 2013Text